Skip to main content

Spin out companies from University of Bath research

Companies that have spun-out of the University of Bath as a result of our research commercialisation.


A colourful graphic of peoples heads with image captions floating above them.
Spin-out companies which have developed from commercialising University of Bath research


  • Prothea Technologies Ltd is a private medical technology company with a vision to offer lung cancer biopsy and treatment in a single hospital visit - spun-out in April 2024


  • Revolver Therapeutics Ltd has developed a proprietary cell-based transcription factor screening technology and associated peptide-based transcription factor inhibitors for the treatment of cancer. Revolver's unique platform identifies peptides that not only bind but also functionally inhibit transcription factors. These peptide inhibitors are stabilised using the company's patented crosslinking technology - spun-out in February 2023


  • IngeniumAI develops software integrated within healthcare systems to help clinicians diagnose diseases more quickly - spun-out in April 2022

  • Aerogel Core Ltd specialises in ultra-light aerogels that can be used as soundproofing and heat-shielding materials for the aerospace and automotive industries - spun-out in April 2022


  • Ensilicated Technologies Ltd (EnsiliTech) develops ensilication technology to prevent degradation and spoilage of vaccines - spun-out in July 2021

  • Transdermal Diagnostics Ltd develops a wearable technology platform to improve the prevention, diagnosis, and management of chronic conditions such as diabetes- spun-out in July 2021

  • Smartwound Ltd improves human health through early detection and treatment of wound, bladder and skin infection, specialising in burn care, diabetic foot ulcer management and urology - spun-out in March 2021


  • BLOC Laboratories created a suite of software tools to help researchers working with biomolecules to rapidly prediction changes in protein stability - incorporated in September 2019


  • Gen3D provides software and consulting solutions for additively manufactured (3D printed) components - spun-out in May 2018 and acquired by Altair in June 2022

  • Naturbeads produces biodegradable cellulose microparticles to replace plastic microbeads - spun-out in May 2018

  • 3UG Autonomous Systems provides risk minimisation, risk quantification and trajectory planning for drone operators and service providers - spun-out in July 2018 and rebranded as Volant Autonomy Ltd in March 2022


  • Ceryx Medical develops bioelectronics based on chip technology to mimic nerve centres within the body to help control autonomic or rhythmical processes such as heart rate - spun-out in February 2016


  • Bath Social and Development Research Ltd gathers, analyses and presents feedback from beneficiaries for an impact assessment of significant drivers of change in their lives - spun-out in December 2015


  • CiteAb is a leading life science data provider for antibodies and biochemicals - spun-out in May 2013

  • Cellesce is a biotech company that has developed a new patented bioprocessing technology for the growing and expansion of organoids - spun-out in April 2013


  • GLOphotonics SAS commercialises hollow-core photonic crystal fiber (HC-PCF) and their functionalised form Photonic Microcells™ (PMC) - spun-out in December 2008


  • Iksuda Therapeutics creates antibody-drug conjugates to target difficult-to-treat cancers including those resistant or refractory to current therapies - spun-out as Glythera Ltd in November 2007 and rebranded as Iksuda Therapeutics Ltd in May 2018

  • Microsulis Medical Limited develops and manufactures microwave ablation devices for minimally invasive soft tissue ablation - spun-out as Microsulis Medical Ltd in August 2007 and acquired by AngioDynamics in March 2022

  • Nano-Purification Solutions Ltd manufactures state-of-the-art compressed air and gas solutions for industry - spun-out in May 2007 and acquired by IMI Norgren in February 2016

  • NanoGaN Ltd provides Nanocolumn technology to develop free standing gallium nitride substrates which are critical for blue and green laser technology and ultra-high brightness LEDs - spun-out in March 2007 and acquired by IQE plc in 2009


  • Bath ASU manufactures pharmaceutical products under parent company Qualasept Pharmaxo Holdings Ltd - spun-out in May 2006


  • Binx Health (Formerly Atlas Genetics) improves sexual health and wellness through new delivery methods - spun-out as Atlas Genetics in July 2005 and rebranded to Binx Health in October 2018


  • Sterix Pharmaceuticals is a biopharmaceutical group improving lives through innovative medicines in oncology, neuroscience and rare diseases - spun-out in March 1997 and acquired by Ipsen in 2004


If you have any questions, please contact us.

On this page